REFRACTIVE LENS EXCHANGE – CLINICAL FRAMEWORK
This page is for patients who want to understand how refractive lens exchange and cataract surgery differ, and why the surgical technique is identical even though the indications are not.
The Procedure Is Identical, The Indication Is Different
Refractive lens exchange (RLE) and cataract surgery involve exactly the same surgical steps: phacoemulsification of the natural crystalline lens through a small corneal incision, followed by insertion of an intraocular lens (IOL) into the capsular bag. The instruments, the technique, the incision size, and the IOL platforms are the same. What differs is the reason the natural lens is being removed.¹
In cataract surgery, the natural lens has become sufficiently opaque to impair visual function.³ The indication is pathological, the lens must be removed because it is no longer transparent. In RLE, the natural lens is clear or only mildly changed, but is removed electively to correct refractive error and, in most cases, presbyopia. The indication is elective. The procedure is identical.
What Changes Between the Two
Cataract surgery: the indication is significant lens opacity impairing vision. Typical patient age is 65-80+. NHS availability applies when vision is impaired. Surgical technique is phacoemulsification. Premium IOL access is limited on the NHS. The outcome expectation is to restore functional vision.⁴
Refractive lens exchange: the indication is elective, a refractive correction goal. Typical patient age is 50-65. NHS availability does not apply, it is an elective procedure. Surgical technique is identical phacoemulsification. Full premium IOL choice is available privately; trifocal is standard at Blue Fin Vision®. The outcome expectation is to achieve spectacle independence.¹
Why RLE Prevents Future Cataract
Once the natural crystalline lens is removed and replaced with an IOL, the capsular bag contains an artificial lens made of a stable acrylic material. This artificial lens cannot develop cataract, by definition, because cataract is the opacity of the natural lens. A patient who has RLE at 55 will never require cataract surgery. This is a meaningful long-term benefit that is often overlooked in RLE decision-making discussions.
Who This Is Not For
This page is not an argument that everyone approaching cataract age should have elective RLE. The risk-benefit calculation of removing a clear lens in a patient with mild refractive error is different from removing a dense cataract with severely impaired vision. The appropriateness of RLE depends on the degree of refractive error, the patient’s lifestyle goals, and the status of the crystalline lens at biometric assessment. These factors are reviewed at every Blue Fin Vision® RLE consultation.
Clinical Perspective
Mr Mfazo Hove, consultant ophthalmic surgeon at Blue Fin Vision®, has performed more than 57,000 cataract and lens procedures across his career. The surgical experience and the technique are identical between RLE and cataract surgery, the difference is in the pre-operative counselling, the IOL selection rationale, and the post-operative expectation framework. Premium IOL implantation, trifocal at Blue Fin Vision® as the standard platform, delivers spectacle independence rates above 90% at twelve months in appropriately selected patients,¹ whether the indication is refractive or cataract.
Clinical Takeaway
RLE and cataract surgery are the same procedure performed for different indications. Phacoemulsification, IOL implantation, and the recovery timeline are identical. RLE eliminates the risk of future cataract development. At Blue Fin Vision®, the same premium IOL platform, ZEISS AT LISA tri 839MP, is used for both, with spectacle independence rates above 90% in appropriately selected patients. If you are considering elective lens surgery and want to understand whether RLE or cataract surgery is the relevant pathway for your clinical picture, book a consultation with Mr Hove.
References
- Rosen E, Alio JL, Dick HB, Dell S, Slade S. Efficacy and safety of multifocal intraocular lenses following cataract and refractive lens exchange: meta-analysis of peer-reviewed publications. J Cataract Refract Surg. 2016;42(2):310-28.
- Lundstrom M, Dickman M, Henry Y, Manning S, Rosen P, Tassignon MJ, et al. Differences between planned and achieved refractive outcomes after cataract surgery in 2017 as registered in the European Registry of Quality Outcomes for Cataract and Refractive Surgery. J Cataract Refract Surg. 2020;46(1):89-95.
- Pesudovs K, Burr JM, Harley C, Elliott DB. The activities of daily vision scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest Ophthalmol Vis Sci. 2007;48(4):1892-901.
- Javitt JC, Wang F, West SK. Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health. 1996;17:159-77.
- Liu YC, Wong TT, Mehta JS. Intraoperative aberrometry versus preoperative biometry for intraocular lens power selection in eyes with previous myopic laser in situ keratomileusis. J Cataract Refract Surg. 2014;40(1):56-62.
